CRVS (CRVS) Stock Price & Analysis
CRVS (CRVS) fell 1.77% to USD 14.39 as of September 8, 2026 at 06:58 UTC, according to Nexqual real-time market data.
CRVS last closed at USD 14.39; the session ranged USD 14.34–14.74 on volume of 626,950 shares. Market capitalization is —, with a 52-week range of USD 5.64–26.95 (NGM). Source: Nexqual, September 8, 2026 at 06:58 UTC.
Key Statistics (as of September 8, 2026 at 06:58 UTC)
| Price | USD 14.39 |
|---|---|
| Change | ▼ 1.77% (down) |
| Previous Close | USD 14.39 |
| Open | USD 14.39 |
| Day Range | USD 14.34 – 14.74 |
| 52-Week Range | USD 5.64 – 26.95 |
| Volume | 626,950 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (CRVS)
Nexqual's technical model rates CRVS "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 06:58 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.62 (neutral) |
| vs SMA50 | Below (USD 14.41) |
| MACD | 0.06 (positive) |
From CRVS's Latest SEC 10-K Filing (filed 2026-03-12)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CYPH | Cypherpunk Technologies Inc. | USD 2.42 | ▲ 44.05% |
| CTMX | CytomX Therapeutics, Inc. | USD 3.71 | ▼ 0.27% |
| EDSA | Edesa Biotech, Inc. | USD 4.73 | ▼ 0.63% |
| PTGX | Protagonist Therapeutics, Inc. | USD 145.72 | ▼ 0.25% |
| ACIU | AC Immune SA | USD 2.86 | ▲ 0.7% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 06:58 UTC. This page is informational and not investment advice.